Clarified Precision Medicine

📣 If you are an oncologist at a community practice or integrated delivery network, a sequencing lab, a payer, or a life sciences company, Clarified Precision Medicine is looking to partner with you to elevate the bar on the practice of precision oncology. Today, targeted therapeutics are tremendously underutilized, while they have been proven to be highly effective. In order to solve this access problem, there needs to be a nuanced detailing of how NGS results are being interpreted today, paired with intervention at the point-of-care that makes this interpretation easier, quicker, and more accurate. Getting to the right therapy at the right time takes a coordinated effort across all stakeholders, and we’re here to make the flywheel turn appropriately and in accordance with medical management guidelines. The journey from genomic sequencing to therapeutic selection in a cancer patient is not well described, and there are massive opportunities for improvement. Check out our storyboard of the problem and solution below, and get it touch to learn more! Rajni Natesan, MD, MBA Howard McLeod Lincoln Nadauld Lisa Alderson Daniel Rotroff Linda Greub, CFA, MBA Rich Schilsky, MD, Roy Beveridge MD #personalizedmedicine #precisiononcology #healthtech #ai

The Clarified Precision Medicine team will be at JPM2025! Ping us to learn more about how we're advancing oncology genomics 🚀 🧬 Rajni Natesan, MD, MBA Howard McLeod Lisa Alderson Lincoln Nadauld Michael Fleming Daniel Rotroff Linda Greub, CFA, MBA Roy Beveridge MD #personalizedmedicine #precisiononcology #healthtech #ai #jpm2025

🌟 By streamlining treatment decisions and matching patients with the most effective therapies sooner, Clarified Precision Medicine avoids costly trial-and-error approaches and improves outcomes. While resource limitations often hinder widespread access to precision oncology, Clarified is committed to breaking down these barriers and making precision oncology the standard of care per medical management guidelines.    Discover how we’re transforming oncology care for the future in our white paper: https://lnkd.in/gk5We_da Rajni Natesan, MD, MBA Lisa Alderson Michael Fleming Lincoln Nadauld Howard McLeod Daniel Rotroff Roy Beveridge MD Linda Greub, CFA, MBA #precisiononcology #healthcareinnovation #personalizedmedicine #AI

Big congratulations to Clarified Precision Medicine, one of the winners of the second edition of Arionkoder Reshape Health Grants! Clarified Precision Medicine is at the forefront of personalized cancer care, using AI-driven analytics to provide patients with precise treatment recommendations. Their work is transforming the way we approach cancer care, offering hope and targeted solutions to those in need. We’ll help them as they innovate in UX and AI to make their mission a reality, and feel honored to collaborate with this incredible team. Howard McLeod Lincoln Nadauld Lisa Alderson Jody Simon Rajni Natesan, MD, MBA Daniel Rotroff Michael Fleming #PrecisionMedicine #AI #HealthTech #Grants #cancer #cancercare

Clarified Precision Medicine is honored to join this transformational cohort of companies selected for an Arionkoder Reshape Health Grant! Congrats to our fellow cohort members, and thank you to Arionkoder for being a part of our tremendous mission.

Arionkoder is a cutting-edge product design studio that helps forward thinking companies, like Clarified Precision Medicine, develop AI-powered technologies to change the landscape of #medicine by delivering on the promise of #precisionmedicine. We are super honored to have made their shortlist of companies for their Arionkoder Reshape Health grants!

👏 Huge shout-out to the The Wall Street Journal and Brianna Abbott for the powerful write-up today on the unsustainable complexity of cancer care entitled, "Cancer Care is Getting Personal. Local Doctors Can’t Keep Up. More drugs, changing guidelines are too much for general oncologists to track." See link to full article here: https://lnkd.in/gnFYpP9K Key messages from the article: >The vast majority of oncology is practiced in the community setting, where patients prefer to be diagnosed and treated. >MD Anderson Cancer Center's Peter Pisters notes that it’s possible that 1 in 5 patients in America is getting the wrong treatment. >The genomics learning curve is too steep. >Guidelines are impossible to keep up with, and almost impossible to read. The National Comprehensive Cancer Network (NCCN) updated its nearly 90 guidelines across cancer types more than 200 times in the past year. >Cancer care is getting more complicated. Doctors now think of cancer as more than 100 distinct diseases. >Community docs often resort to cold-calling specialists at big centers for advice on the best way to treat their patients, in a way that is not scalable. What is the answer here to support our valuable community oncologists and their patients? Timely and scalable genomics expertise. We have the ability to solve this now, for any patient, anywhere, and it’s the very reason we built Clarified Precision Medicine. With a combination of human+AI, Clarified closes this critical care gap at the last mile of cancer care. Lisa Alderson Michael Fleming Howard McLeod Lincoln Nadauld Roy Beveridge MD Daniel Rotroff Linda Greub, CFA, MBA Tracy Dooley MD

Busy oncologists who don’t have enough time in their day to engage with Molecular Tumor Boards on a regular basis. MTB-centric studies that often require extended time frames – sometimes up to a month – to review patients’ test reports. Entire teams dedicated to getting oncologists connected to MTBs, completing necessary paperwork, and trying to make precision medicine work for oncology practices. ➡️ We have what it takes to solve these challenges. ⬅️ These precision oncology obstacles, addressed in a recent article from Precision Medicine Online, are the types of hurdles that our “AI+expert human” platform overcomes every day. We bring the type of expertise provided by MTB’s into busy oncology offices, smoothly and simply, so that clinicians can give their patients the most advanced care. Please DM us to learn more. And you’ll find the full Precision Medicine Online article here (subscription required) >> https://lnkd.in/gCDjKBtX Howard McLeod Lincoln Nadauld Daniel Rotroff Roy Beveridge MD Rajni Natesan, MD, MBA Lisa Alderson Alison Kanski #AI #healthcare #healthtech #precisionmedicine #precisiononcology #clarifiedprecisionmedicine

The scale of AI, overseen by veteran medical expertise. That’s the combination that gives Clarified a true edge in precision oncology. In this latest episode of BRight Minds in Healthcare Delivery, our CEO Rajni Natesan talks with Alex Nisenbaum of Blank Rome LLP about how Clarified’s fusion of machine learning and human experience yields new possibilities for cancer patients in need of timely, actionable precision medicine. Listen to the full episode here: bit.ly/4eyHCYT Rajni Natesan, MD, MBA Howard McLeod Lisa Alderson Lincoln Nadauld Daniel Rotroff Michael Fleming #precisionmedicine #molecularprofiling #precisiononcology #oncology #clarifiedprecisionmedicine

How is technology revolutionizing healthcare delivery? In the latest episode of BRight Minds in Healthcare Delivery, Rajni Natesan, MD, MBA, CEO of Clarified Precision Medicine, joins Blank Rome's Alex Nisenbaum in a thought-provoking discussion on leveraging machine learning algorithms and artificial intelligence to enhance health outcomes. They also delve into the challenges that impact the implementation of these innovative tools. Listen now: bit.ly/4eyHCYT #healthcare #healthcarelaw #healthcaredelivery